Basic Information
| LncRNA/CircRNA Name | RCOR3-013 |
| Synonyms | NONHSAT009284 |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | intrahepatic cholangiocarcinoma |
| ICD-0-3 | C22 |
| Methods | qPCR |
| Sample | intrahepatic cholangiocarcinoma tissues |
| Expression Pattern | up-regulated |
| Function Description | We observed the same expression patterns as microarray analysis between ICC tumors and adjacent tissues for RCOR3-013 (95% CI (0.106, 2.479), P = 0.034) with statistical significance, ATF3-008 (95% CI (-1.753, 0.694), P = 0.385) |
| Pubmed ID | 28401021 |
| Year | 2017 |
| Title | Integrated mRNA and lncRNA expression profiling for exploring metastatic biomarkers of human intrahepatic cholangiocarcinoma |
External Links
| Links for RCOR3-013 | GenBank HGNC NONCODE |
| Links for intrahepatic cholangiocarcinoma | OMIM COSMIC |